UroGen Pharma Ltd. (URGN)

28.92 USD+2.92%
Gurus hold2popularity #828 of 1982
Net buying (quarter)−$1.2M1 buying · 1 selling
Market Cap$1.42B
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossEPS -1.31

UroGen Pharma Ltd. (URGN) is not among the 30 most-held stocks of the tracked superinvestor set. Price 28.92 USD; market cap $1.42B.

Guru Ownership

Popularity rank#828 of 1,982 securities
gurus hold it2
Net activity this quarter−$1.2M

Guru count: the consensus-panel funds (wide books such as Citadel or Renaissance excluded) holding the stock at quarter end; the header and the history table use the same definition.

What changed this quarter
$698.3K · 0 new buys · 1 added $1.9M · 1 reduced · 0 sold out1 net buyers · 1 net sellers
Top 5 by conviction
Top 5 by value

Price & valuation

Prev Close28.1
Open28.61
Day Range27.08 – 29.38
52 Week Range—
Volume—
Avg Volume (3M)—
Market Cap$1.42BSEC 10-Q, 10/28/2026
BetaVolatility vs the market. Above 1: swings harder than the index.1.312 years, weekly, vs SPY
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossSEC 10-Q, 09/30/2026
EPS (TTM)Annual net profit per share.-1.31SEC 10-Q, 09/30/2026
Dividend YieldAnnual dividend over share price.—

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Frequently Asked Questions

Which superinvestors own URGN?

UroGen Pharma Ltd. (URGN) is not among the 30 most-held stocks of the tracked superinvestor set.

Is institutional sentiment on URGN bullish or bearish?

URGN is not among the 30 most-held stocks of the superinvestor set, so net buyer/seller counts are not computed for it.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.